Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 10;21(2):209.
doi: 10.3390/molecules21020209.

Chemical Characterization and Trypanocidal, Leishmanicidal and Cytotoxicity Potential of Lantana camara L. (Verbenaceae) Essential Oil

Affiliations

Chemical Characterization and Trypanocidal, Leishmanicidal and Cytotoxicity Potential of Lantana camara L. (Verbenaceae) Essential Oil

Luiz Marivando Barros et al. Molecules. .

Abstract

Drug resistance in the treatment of neglected parasitic diseases, such as leishmaniasis and trypanosomiasis, has led to the search and development of alternative drugs from plant origins. In this context, the essential oil extracted by hydro-distillation from Lantana camara leaves was tested against Leishmania braziliensis and Trypanosoma cruzi. The results demonstrated that L. camara essential oil inhibited T. cruzi and L. braziliensis with IC50 of 201.94 μg/mL and 72.31 μg/mL, respectively. L. camara essential oil was found to be toxic to NCTC929 fibroblasts at 500 μg/mL (IC50 = 301.42 μg/mL). The composition of L. camara essential oil analyzed by gas chromatography-mass spectrometry (GC/MS) revealed large amounts of (E)-caryophyllene (23.75%), biciclogermacrene (15.80%), germacrene D (11.73%), terpinolene (6.1%), and sabinene (5.92%), which might be, at least in part, responsible for its activity. Taken together, our results suggest that L. camara essential oil may be an important source of therapeutic agents for the development of alternative drugs against parasitic diseases.

Keywords: Lantana camara; Leishmania braziliensis; Trypanosoma cruzi; essential oil.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. WHO-World Health Organization Leishmaniasis Magnitude of the Problem, 2010. [(assessed on 1 October 2015)]. Available online: http://www.who.int/leishmaniasis/burden/magnitude/burden_magnitude/en/pr....
    1. Shaw J.J. Taxonomy of the genus Leishmania: Present and future trends and their implications. Mem. Inst. Oswaldo Cruz. 1994;89:471–478. doi: 10.1590/S0074-02761994000300033. - DOI - PubMed
    1. Desjeux P. Leishmaniasis: Public health aspects and control. Clin. Dermatol. 1996;14:417–423. doi: 10.1016/0738-081X(96)00057-0. - DOI - PubMed
    1. Ashford R.W. The leishmaniases as model zoonoses. Ann. Trop. Med. Parasitol. 1997;91:693–701. doi: 10.1080/00034989760428. - DOI - PubMed
    1. Herwaldt B.L. Leishmaniasis. Lancet. 1999;354:1191–1199. doi: 10.1016/S0140-6736(98)10178-2. - DOI - PubMed

Publication types

LinkOut - more resources